Sagimet Biosciences (SGMT) Total Current Liabilities (2023)
Sagimet Biosciences (SGMT) has 1 years of Total Current Liabilities data on record, last reported at $5.7 million in Q4 2023.
- For Q4 2023, Total Current Liabilities changed N/A year-over-year to $5.7 million; the TTM value through Dec 2023 reached $5.7 million, changed N/A, while the annual FY2023 figure was $5.7 million, N/A changed from the prior year.
- Total Current Liabilities reached $5.7 million in Q4 2023 per SGMT's latest filing, up from $5.0 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $5.7 million in Q4 2023 and bottomed at $5.0 million in Q3 2023.